Ranganath, T., Simpson, L. J., Seiler, C., Ferreira, A., Vendrame, E., Zhao, N. Q., . . . Blish, C. A. (2019, December 5). Characterization of the impact of daclizumab beta on circulating natural killer cells by mass cytometry bioRxiv. https://doi.org/10.1101/865477
Chicago Style (17th ed.) CitationRanganath, Thanmayi, Laura Jane Simpson, Christof Seiler, Anne-Maud Ferreira, Elena Vendrame, Nancy Q. Zhao, Jason D. Fontenot, Susan P. Holmes, and Catherine A. Blish. "Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry." BioRxiv 5 Dec. 2019. https://doi.org/10.1101/865477.
MLA (9th ed.) CitationRanganath, Thanmayi, et al. "Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry." BioRxiv, 5 Dec. 2019, https://doi.org/10.1101/865477.